Neoadjuvant Cisplatin, Methotrexate and Vinblastine for Muscle-Invasive Bladder Cancer: Long-Term Followup
Author:
Affiliation:
1. From the Department of Urology, University of Iowa College of Medicine, Iowa City, Iowa
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference15 articles.
1. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study;Harker;J. Clin. Oncol.,1985
2. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium;Sternberg;J. Urol,1985
3. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion;Scher;J. Urol.,1988
4. A prospective randomized trial comparing M-VAC and CISCA chemotherapy for patients with metastatic urothelial tumors;Logothetis;J. Clin. Oncol.,1990
5. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience;Tannock;J. Urol.,1989
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility;Anticancer Research;2017-10-23
2. Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis;European Urology;2014-02
3. Neoadjuvant chemotherapy in invasive bladder cancer;Expert Review of Anticancer Therapy;2005-12
4. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies;Nature Clinical Practice Urology;2005-01
5. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy;Cancer;2004
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3